9164 J. Am. Chem. Soc., Vol. 119, No. 39, 1997
Inouye et al.
subjected to column chromatography (silica gel; eluent, CH2Cl2:AcOEt
) 5:1) to give 16: yield ) 70% (1.89 g, 5.61 mmol); mp 92-94 °C;
IR (KBr) 2962, 1701, 1653, 1578, 1527, 1523, 1450, 1331, 1261, 1161,
amount of concentrated HCl aqueous solution (several drops) was
refluxed for 1 h. The reaction mixture was neutralized to pH 7 with
1 N NaOH aqueous solution and evaporated. The residue was dissolved
in water and extracted with CH2Cl2. The CH2Cl2 extract was evaporated
to give 6: yield ) 75% (249 mg, 0.94 mmol); mp 52-54 °C; IR (KBr)
2926, 2873, 1655, 1606, 1570, 1522, 1456, 1336, 1300, 1221, 1178,
1107, 1076, 1022, 928, 770 cm-1; 1H NMR (CDCl3) δ 3.50-3.83 (m,
4H), 4.58 (s, 2H), 7.06 (d, J ) 9.2 Hz, 1H), 8.27 (d, J ) 9.2 Hz, 1H),
10.56 (s, 1H), 12.38 (s, 1H); 13C NMR (CDCl3) δ 59.20, 61.85, 71.87,
102.36, 118.95, 132.74, 166.01, 196.70; MS m/e (rel intensity) 265
(M+, 20).
Benzo-15-crown-5-Substituted exo-Methyleneindoline 7. To a
CH3CN (5 mL) solution of 5 (169 mg, 0.40 mmol) was added methyl
iodide (284 mg, 2.0 mmol) dropwise at room temperature. The reaction
mixture was stirred at 50 °C for 7 h. After removal of the solvent, the
residue was dissolved in water. The aqueous solution was washed with
ether in order to remove the unreacted starting materials and basified
to pH 9-10 by the addition of 1 N KOH aqueous solution. The
aqueous solution was extracted with CH2Cl2, and the CH2Cl2 extract
was evaporated. The residue was chromatographed (silica gel; eluent,
CHCl3:hexane:Et3N ) 20:30:1) to give 7: yield ) 45% (79 mg, 0.18
mmol); oil; 1H NMR (CDCl3) δ 3.05 (s, 3H), 3.20 (s, 4H), 3.79-3.86
(m, 9H), 3,87 (s, 1H), 3.91-3.94 (m, 4H), 4.12-4.15 (m, 4H), 6.55
(d, J ) 7.9 Hz, 1H), 6.64 (t, J ) 6.7, 1H), 6.76 (s, 2H), 6.84 (d, J )
6.7 Hz, 1H), 7.13 (t, J ) 7.9 Hz, 1H); 13C NMR (CDCl3) δ 28.84,
49.96, 54.93, 69.31, 69.71, 70.52, 71.01, 73.65, 104.91, 110.63, 118.59,
121.42, 127.85, 134.42, 137.35, 146.51, 148.47, 162.07; MS m/e (rel
intensity) 437 (M+, 94).
1
1107, 1091, 964, 935, 800 cm-1; H NMR (CDCl3) δ 3.51 (s, 3H),
5.32 (s, 2H), 7.33 (d, J ) 9.2 Hz, 1H), 7.85 (d, J ) 9.2 Hz, 1H), 10.09
(s, 1H); 13C NMR (CDCl3) δ 56.98, 87.95, 95.14, 115.30, 129.01,
159.71, 191.48; MS m/e (rel intensity) 337 (M+, 75).
2-[1,4-Dioxa-7-(tri-n-butylstannyl)hept-6-ynyl]tetrahydropyran
(17). To an Et2O (100 mL) solution of ethylene glycol (9.31 g, 150
mmol) containing a small amount of concentrated HCl aqueous solution
(several drops) was added 3,4-dihydro-2H-pyran (DHP) (13.44 g, 160
mmol) at room temperature. The reaction mixture was stirred at this
temperature for 2 h. After addition of finely ground K2CO3 (2.0 g),
the reaction mixture was stirred for an additional 10 min and filtered.
The filtrate was evaporated, and the residue was subjected to column
chromatography (silica gel; eluent, AcOEt) to give 2-(2-hydroxy-
ethoxy)tetrahydropyran: yield ) 41% (9.00 g, 61.6 mmol); oil; IR
(KBr) 3435, 2943, 2871, 1456, 1351, 1201, 1161, 1124, 1072, 1033,
1
985, 870 cm-1; H NMR (CDCl3) δ 1.51-1.86 (m, 6H), 2.81 (br s,
1H), 3.51-3.59 (m, 1H), 3.69-3.81 (m, 4H), 3.89-3.98 (m, 1H), 4.56-
4.59 (m, 1H); 13C NMR (CDCl3) δ 20.04, 25.24, 30.82, 62.33, 63.32,
70.82, 100.22; MS m/e (rel intensity) 146 (M+, 8). To a THF (50 mL)
suspension of NaH (2.00 g, 50 mmol; commercial 60% dispersion was
washed thoroughly with hexane prior to use) was added 2-(2-
hydroxyethoxy)tetrahydropyran (9.00 g, 61.6 mmol) dropwise at 0 °C,
and the reaction mixture was stirred for 30 min at the same temperature.
Propargyl bromide (7.14 g, 60.0 mmol) was added dropwise to the
solution at the same temperature. The reaction mixture was stirred at
room temperature for an additional 15 h. After removal of the solvent,
the residue was dissolved in water and extracted with CHCl3. The
CHCl3 extract was evaporated and distilled under reduced pressure to
give 2-(1,4-dioxahept-6-ynyl)tetrahydropyran: yield ) 57% (6.45 g,
35.0 mmol); bp 90-95 °C (4 mmHg); oil; IR (KBr) 3290, 3255, 2943,
2872, 1442, 1354, 1201, 1124, 1076, 1036, 985, 930, 872, 814, 673
Crown Spirobenzopyran 2. To an EtOH (1.5 mL) solution of 6
(48 mg, 0.18 mmol) was added an EtOH (1.5 mL) solution of 7 (79
mg, 0.18 mmol) dropwise at room temperature. The reaction mixture
was refluxed for 3 h. After removal of the solvent, the residue was
chromatographed (silica gel; eluent, CHCl3:EtOH ) 15:1) to give 2:
yield ) 43% (53 mg, 0.077 mmol); mp 117-120 °C; IR (KBr) 3359,
1
cm-1; H NMR (CDCl3) δ 1.49-1.99 (m, 6H), 2.43 (t, J ) 2.4 Hz,
1
2870, 1564, 1506, 1454, 1327, 1288, 941, 748 cm-1; H NMR (500
1H), 3.47-3.55 (m, 1H), 3.59-3.69 (m, 1H), 3.73 (t, J ) 4.1 Hz, 2H),
3.84-3.94 (m, 2H), 4.23 (d, J ) 2.4 Hz, 2H), 4.64 (t, J ) 4.1 Hz,
1H); 13C NMR (CDCl3) δ 19.50, 25.46, 30.58, 58.45, 62.31, 66.50,
69.15, 74.44, 79.80, 98.98; MS m/e (rel intensity) 184 (M+, 2). To a
THF (60 mL) solution of 2-(1,4-dioxahept-6-ynyl)tetrahydropyran (2.76
g, 15.0 mmol) was added an n-hexane solution of n-BuLi (13.5 mmol)
dropwise at 0 °C. After stirring at that temperature for 30 min, to the
solution was added tri-n-butyltin chloride (3.91 g, 12.0 mmol) at the
same temperature. The reaction mixture was stirred at room temper-
ature for an additional 15 h. After removal of the solvent, the residue
was dissolved in brine and extracted with CHCl3. The CHCl3 extract
was evaporated and distilled under reduced pressure to give 17: yield
) 80% (5.68 g, 12.0 mmol); bp 210-215 °C (4 mmHg); IR (KBr)
2927, 2852, 1524, 1464, 1342, 1201, 1124, 1076, 1036, 962, 874, 816,
MHz, CD3CN) δ 2.60 (d, J ) 15.5 Hz, 1H), 2.73 (s, 3H), 2.81 (br s,
1H), 3.13 (d J ) 15.5 Hz, 1H), 3.15 (d, J ) 15.5 Hz, 1H), 3.42 (d, J
) 15.5 Hz, 1H), 3.60-3.70 (m, 12H), 3.71-3.83 (m, 4H), 3.92-4.08
(m, 4H), 4.51 (s, 2H), 6.06 (d, J ) 10.6 Hz, 1H), 6.64 (d, J ) 7.3 Hz,
1H), 6.71 (s, 1H), 6.74 (t, J ) 7.3 Hz, 1H), 6.76 (s, 1H), 6.78 (d, J )
9.2 Hz, 1H), 6.84 (d, J ) 7.3 Hz, 1H), 7.18 (t, J ) 7.3 Hz, 1H), 7.28
(d, J ) 10.6 Hz, 1H), 7.93 (d, J ) 9.2 Hz, 1H); 13C NMR (CDCl3) δ
28.98, 29.71, 38.36, 42.00, 59.26, 61.81, 64.58, 69.06, 69.19, 69.49,
70.32, 70.80, 71.55, 79.25, 98.62, 105.11, 107.29, 110.20, 115.36,
115.86, 119.88, 121.34, 122.80, 125.66, 126,76, 128.23, 133.31, 134.08,
135.43, 143.01, 147.82, 148.41, 158.51; FABMS (in 3-nitrobenzyl
alcohol) m/e (rel intensity) 685 (MH+, 100).
Benzo-15-crown-5-Substituted exo-Methyleneindoline 8. To a
CH3CN (10 mL) solution of 5 (318 mg, 0.75 mmol) was added ethyl
bromoacetate (626 mg, 3.75 mmol) dropwise at room temperature. The
reaction mixture was stirred at 50 °C for 12 h. After removal of the
solvent, the residue was dissolved in water. The aqueous solution was
washed with ether in order to remove the unreacted starting materials
and basified to pH 9-10 by the addition of K2CO3 aqueous solution.
The aqueous solution was extracted with CH2Cl2, and the CH2Cl2 extract
was evaporated. The residue was chromatographed (silica gel; eluent,
AcOEt:Et3N ) 30:1) to give 8: yield ) 45% (171 mg, 0.34 mmol);
oil; 1H NMR (CDCl3) δ 1.25 (t, J ) 3.1 Hz, 3H), 3.22 (s, 4H), 3.75-
3.80 (m, 9H), 3.87-3.99 (m, 4H), 4.06-4.24 (m, 7H), 6.53 (d, J )
6.7 Hz, 1H), 6.64 (t, J ) 6.7 Hz, 1H), 6.76 (s, 2H), 6.84 (d, J ) 6.7
Hz, 1H), 7.12 (t, J ) 6.7 Hz, 1H); MS m/e (rel intensity) 509 (M+,
26).
1
671 cm-1; H NMR (CDCl3) δ 0.90 (t, J ) 6.8 Hz, 9H), 0.99 (t, J )
7.3 Hz, 6H), 1.26-1.40 (m, 6H), 1.47-1.77 (m, 12H), 3.47-3.54 (m,
1H), 3.60-3.69 (m, 1H), 3.70-3.78 (m, 2H), 3.83-3.93 (m, 2H), 4.24
(d, J ) 1.1 Hz, 2H), 4.64 (t, J ) 3.2 Hz, 1H); 13C NMR (CDCl3) δ
11.07, 13.64, 19.48, 25.50, 26.98, 28.88, 30.58, 59.38, 62.21, 66.52,
68.68, 89.78, 98.90, 105.92.
6-(Methoxymethoxy)-3-nitro-2-[4-oxa-6-(tetrahydropyranyloxy)-
hex-1-ynyl]benzaldehyde (18). To a toluene (3.0 mL) suspension of
16 (505 mg, 1.50 mmol) and (PPh3)2PdCl2 (42 mg, 0.06 mmol) was
added 17 (1065 mg, 2.25 mmol) dropwise at room temperature. The
reaction mixture was stirred at 80 °C for 3 h. The reaction mixture
was chromatographed (silica gel; eluent, CH2Cl2:AcOEt ) 5:1) to give
18: yield ) 83% (490 mg, 1.25 mmol); oil; IR (KBr) 2870, 1709,
1574, 1462, 1352, 1279, 1201, 1097, 1036, 1020, 949, 926, 908, 872,
810, 731 cm-1; 1H NMR (CDCl3) δ 1.48-1.88 (m, 6H), 3.53 (s, 3H),
3.50-3.54 (m, 1H), 3.65-3.72 (m, 1H), 3.84-3.99 (m, 4H), 4.56 (d,
J ) 1.6 Hz, 2H), 4.67 (t, J ) 3.8 Hz, 1H), 5.37 (s, 2H), 7.31 (d, J )
9.2 Hz, 1H), 8.16 (d, J ) 9.2 Hz, 1H), 10.57 (s, 1H); 13C NMR (CDCl3)
δ 19.44, 25.42, 30.50, 56.94, 59.08, 62.23, 66.46, 69.45, 94.94, 98.86,
101.39, 114.89, 120.59, 127.06, 130.11, 145.07, 160.84, 188.66; MS
m/e (rel intensity) 393 (M+, 9).
Ester-Substituted Crown Spirobenzopyran 9. To an EtOH (4 mL)
solution of 6 (80 mg, 0.30 mmol) was added a CH2Cl2 (4 mL) solution
of 8 (152 mg, 0.30 mmol) dropwise at room temperature. The reaction
mixture was stirred at 50 °C for 4 h. After removal of the solvent, the
residue was chromatographed (silica gel; eluent, CH2Cl2:MeOH ) 15:
1) to give 9: yield ) 46% (104 mg, 0.14 mmol). This compound was
used for the next reaction without further purification and identification.
Carboxylic Acid-Substituted Crown Spirobenzopyran 10. To a
THF (10 mL) solution of 9 (104 mg, 0.14 mmol) was added 1 N KOH
aqueous solution (3 mL). The reaction mixture was stirred at room
6-(6-Hydroxy-4-oxahex-1-ynyl)-5-nitrosalicylaldehyde (6).
A
MeOH (30 mL) solution of 18 (490 mg, 1.25 mmol) containing a small